BRUSSELS, April 24 (Reuters) - Belgian pharmaceutical group UCB said on Thursday it had little doubt that its Cimzia drug would be cleared by European authorities to treat bowel disorder Crohn’s disease.
BRUSSELS, April 24 (Reuters) - Belgian pharmaceutical group UCB said on Thursday it had little doubt that its Cimzia drug would be cleared by European authorities to treat bowel disorder Crohn’s disease.
